These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 15509549)
1. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Gylys KH; Fein JA; Yang F; Wiley DJ; Miller CA; Cole GM Am J Pathol; 2004 Nov; 165(5):1809-17. PubMed ID: 15509549 [TBL] [Abstract][Full Text] [Related]
2. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease. Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609 [TBL] [Abstract][Full Text] [Related]
3. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex. Gylys KH; Fein JA; Yang F; Miller CA; Cole GM Neurobiol Aging; 2007 Jan; 28(1):8-17. PubMed ID: 16332401 [TBL] [Abstract][Full Text] [Related]
4. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Ingelsson M; Fukumoto H; Newell KL; Growdon JH; Hedley-Whyte ET; Frosch MP; Albert MS; Hyman BT; Irizarry MC Neurology; 2004 Mar; 62(6):925-31. PubMed ID: 15037694 [TBL] [Abstract][Full Text] [Related]
5. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692 [TBL] [Abstract][Full Text] [Related]
6. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. Bilousova T; Miller CA; Poon WW; Vinters HV; Corrada M; Kawas C; Hayden EY; Teplow DB; Glabe C; Albay R; Cole GM; Teng E; Gylys KH Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979 [TBL] [Abstract][Full Text] [Related]
7. Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex. Gylys KH; Fein JA; Yang F; Cole GM Cytometry A; 2004 Jul; 60(1):90-6. PubMed ID: 15229861 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease. Kurucu H; Colom-Cadena M; Davies C; Wilkins L; King D; Rose J; Tzioras M; Tulloch JH; Smith C; Spires-Jones TL Eur J Neurol; 2022 May; 29(5):1311-1323. PubMed ID: 34331352 [TBL] [Abstract][Full Text] [Related]
10. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease. Canas PM; Simões AP; Rodrigues RJ; Cunha RA Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236 [TBL] [Abstract][Full Text] [Related]
11. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Greber S; Lubec G; Cairns N; Fountoulakis M Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268 [TBL] [Abstract][Full Text] [Related]
12. High levels of synaptosomal Na(+)-Ca(2+) exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer's disease. Sokolow S; Luu SH; Headley AJ; Hanson AY; Kim T; Miller CA; Vinters HV; Gylys KH Cell Calcium; 2011 Apr; 49(4):208-16. PubMed ID: 21382638 [TBL] [Abstract][Full Text] [Related]
14. Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease. Amorim JA; Canas PM; Tomé AR; Rolo AP; Agostinho P; Palmeira CM; Cunha RA J Alzheimers Dis; 2017; 60(2):525-536. PubMed ID: 28869472 [TBL] [Abstract][Full Text] [Related]
15. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. Yuki D; Sugiura Y; Zaima N; Akatsu H; Takei S; Yao I; Maesako M; Kinoshita A; Yamamoto T; Kon R; Sugiyama K; Setou M Sci Rep; 2014 Nov; 4():7130. PubMed ID: 25410733 [TBL] [Abstract][Full Text] [Related]
16. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease. Pickett EK; Rose J; McCrory C; McKenzie CA; King D; Smith C; Gillingwater TH; Henstridge CM; Spires-Jones TL Acta Neuropathol; 2018 Nov; 136(5):747-757. PubMed ID: 30191401 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Postupna NO; Keene CD; Latimer C; Sherfield EE; Van Gelder RD; Ojemann JG; Montine TJ; Darvas M Lab Invest; 2014 Oct; 94(10):1161-72. PubMed ID: 25068655 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses. Willén K; Sroka A; Takahashi RH; Gouras GK J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466 [TBL] [Abstract][Full Text] [Related]
19. [Effect of beta-amyloid peptides on alpha-7 nicotinic receptor status in astrocytes and neurons, and its relationship to pathogenesis of Alzheimer's disease]. Xiao Y; Shan KR; Guan ZZ Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):462-6. PubMed ID: 17069698 [TBL] [Abstract][Full Text] [Related]
20. Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. Leuba G; Savioz A; Vernay A; Carnal B; Kraftsik R; Tardif E; Riederer I; Riederer BM J Alzheimers Dis; 2008 Sep; 15(1):139-51. PubMed ID: 18780974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]